4//SEC Filing
WEISSMAN IRVING 4
Accession 0001209191-20-023724
CIK 0001667633other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 12:28 PM ET
Size
14.8 KB
Accession
0001209191-20-023724
Insider Transaction Report
Form 4
WEISSMAN IRVING
Director
Transactions
- Gift
Common Stock
2020-03-27−16,772→ 1,456,989 total(indirect: By Trust) - Disposition to Issuer
Common Stock
2020-04-07−1,456,989→ 0 total(indirect: By Trust) - Disposition to Issuer
Stock Option (right to buy)
2020-04-07−20,645→ 0 totalExercise: $8.76Exp: 2028-04-26→ Common Stock (20,645 underlying) - Gift
Common Stock
2020-03-26−279,000→ 1,473,761 total(indirect: By Trust) - Disposition to Issuer
Stock Option (right to buy)
2020-04-07−10,322→ 0 totalExercise: $10.81Exp: 2029-06-11→ Common Stock (10,322 underlying)
Footnotes (4)
- [F1]Shares held by Ann Tsukamoto and Irving Weissman, Trustees of The Tsukamoto-Weissman 2011 Trust dated March 16, 2011, as community property.
- [F2]Disposed of pursuant to an agreement and plan of merger by and between the Issuer, Gilead Sciences, Inc. ("Gilead") and Toro Merger Sub, Inc. ("Purchaser") (the "Merger") in exchange for $95.50 per share, net to the holder in cash, without interest and subject to any withholding of taxes, upon the terms and subject to the conditions described in the Offer to Purchase dated March 10, 2020 (together with any amendments or supplements thereto, the "Offer to Purchase") and in the accompanying Letter of Transmittal (together with any amendments or supplements thereto), which are annexed to and filed with the Schedule TO as Exhibits (a)(1)(A) and (a)(1)(B), respectively.
- [F3]This option, which provided for vesting over a three-year period as follows: 1/36th of the shares subject to the option vest in a series of 36 successive equal monthly installments beginning on the date of the closing of the Issuer's initial public offering, subject to Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $1,790,798.91, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option.
- [F4]This option, which provided for vesting on the one-year anniversary of the grant date, subject to Reporting Person's continuous service on such date, was canceled in the Merger in exchange for a cash payment of $874,170.18, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option.
Documents
Issuer
Forty Seven, Inc.
CIK 0001667633
Entity typeother
Related Parties
1- filerCIK 0001230630
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 12:28 PM ET
- Size
- 14.8 KB